[Chemotherapy of renal cell carcinoma. 3. Single-agent therapy with FT-207 or vinblastine].
D000230:Adenocarcinoma / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D007275:Injections, Intravenous; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D005641:Tegafur / Q000627:therapeutic use*; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D005641:Tegafur; D014747:Vinblastine; D005472:Fluorouracil